bosentan anhydrous has been researched along with Hemorrhage, Subarachnoid in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Algra, A; Rinkel, GJ; Vergouwen, MD | 1 |
| Bodock, MJ; Buonanno, FS; Carter, BS; Koroshetz, WJ; Nogueira, RG; Ogilvy, CS; Pryor, JC; Topcuoglu, MA | 1 |
| Hino, A; Johns, LM; Kim, CJ; Macdonald, RL; Thisted, RA; Weir, BK | 1 |
| Clozel, JP; Clozel, M; Gray, GA; Löffler, BM; Roux, S; Sprecher, U | 1 |
| Breu, V; Hallak, H; Lewis, AI; Rapoport, RM; Soattin, GB; Zuccarello, M | 1 |
| Löffler, BM; Seifert, V; Stenzel, W; Stolke, D; Zimmermann, M | 1 |
| Seifert, V; Zimmermann, M | 1 |
| Breu, V; Clozel, M; Ertel, SI; Roux, S | 1 |
| Elghozi, JL; Fassot, C; Friberg, P; Lambert, E; Lambert, G | 2 |
| Clozel, M | 1 |
3 review(s) available for bosentan anhydrous and Hemorrhage, Subarachnoid
| Article | Year |
|---|---|
Endothelin receptor antagonists for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update.
Topics: Bosentan; Contraindications; Dioxanes; Endothelin Receptor Antagonists; Humans; Incidence; Peptides, Cyclic; Pyridines; Pyrimidines; Receptors, Endothelin; Subarachnoid Hemorrhage; Sulfonamides; Tetrazoles; Treatment Outcome; Vasospasm, Intracranial | 2012 |
Endothelin antagonism with bosentan: a review of potential applications.
Topics: Animals; Antihypertensive Agents; Bosentan; Endothelins; Heart Failure; Humans; Hypertension; Kinetics; Rats; Subarachnoid Hemorrhage; Sulfonamides; Time Factors | 1999 |
Endothelin receptor antagonists: current status and perspectives.
Topics: Animals; Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Heart Failure; Humans; Hypertension; Subarachnoid Hemorrhage; Sulfonamides; Vasospasm, Intracranial | 2000 |
1 trial(s) available for bosentan anhydrous and Hemorrhage, Subarachnoid
| Article | Year |
|---|---|
High-dose bosentan in the prevention and treatment of subarachnoid hemorrhage-induced cerebral vasospasm: an open-label feasibility study.
Topics: Adult; Antihypertensive Agents; Bosentan; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Feasibility Studies; Female; Humans; Male; Middle Aged; Pilot Projects; Subarachnoid Hemorrhage; Sulfonamides; Vasospasm, Intracranial | 2007 |
7 other study(ies) available for bosentan anhydrous and Hemorrhage, Subarachnoid
| Article | Year |
|---|---|
Prospective, randomized, double-blind trial of BQ-123 and bosentan for prevention of vasospasm following subarachnoid hemorrhage in monkeys.
Topics: Analysis of Variance; Animals; Blood Flow Velocity; Bosentan; Carotid Artery, Internal; Cerebral Angiography; Cerebral Arteries; Double-Blind Method; Drug Administration Schedule; Drug Evaluation, Preclinical; Endothelins; Ischemic Attack, Transient; Macaca fascicularis; Peptides, Cyclic; Prospective Studies; Random Allocation; Subarachnoid Hemorrhage; Sulfonamides; Ultrasonography, Doppler, Transcranial; Vasodilation | 1995 |
The role of endothelin in experimental cerebral vasospasm.
Topics: Animals; Basilar Artery; Bosentan; Cerebral Angiography; Disease Models, Animal; Dogs; Endothelin Receptor Antagonists; Endothelins; In Vitro Techniques; Ischemic Attack, Transient; Muscle, Smooth, Vascular; Rabbits; Receptors, Endothelin; Subarachnoid Hemorrhage; Sulfonamides; Time Factors | 1995 |
Prevention of subarachnoid hemorrhage-induced cerebral vasospasm by oral administration of endothelin receptor antagonists.
Topics: Administration, Oral; Animals; Basilar Artery; Bosentan; Dioxoles; Endothelin Receptor Antagonists; Ischemic Attack, Transient; Male; Rabbits; Subarachnoid Hemorrhage; Sulfonamides; Vasoconstriction | 1996 |
Prevention of cerebral vasospasm after experimental subarachnoid hemorrhage by RO 47-0203, a newly developed orally active endothelin receptor antagonist.
Topics: Administration, Oral; Animals; Basilar Artery; Bosentan; Cerebral Angiography; Dogs; Dose-Response Relationship, Drug; Drug Administration Schedule; Endothelin Receptor Antagonists; Female; Ischemic Attack, Transient; Male; Receptors, Endothelin; Subarachnoid Hemorrhage; Sulfonamides; Vascular Resistance | 1996 |
[Prevention of cerebral vasospasms after experimental subarachnoid hemorrhage by the endothelin receptor antagonist RO 47-0203].
Topics: Animals; Basilar Artery; Bosentan; Cerebral Angiography; Dogs; Dose-Response Relationship, Drug; Drug Administration Schedule; Endothelin Receptor Antagonists; Endothelins; Infusions, Intra-Arterial; Ischemic Attack, Transient; Receptors, Endothelin; Subarachnoid Hemorrhage; Sulfonamides; Vascular Resistance | 1996 |
Subarachnoid hemorrhage induced sympathoexcitation arises due to changes in endothelin and/or nitric oxide activity.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Bosentan; Endothelins; Heart Rate; Male; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Rats; Rats, Wistar; Subarachnoid Hemorrhage; Sulfonamides; Sympathetic Nervous System | 2000 |
Subarachnoid haemorrhage-induced sympathoexcitation in rats is reversed by bosentan or sodium nitroprusside.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Bosentan; Heart Rate; Hemodynamics; Male; Nitric Oxide Donors; Nitroprusside; Rats; Rats, Wistar; Subarachnoid Hemorrhage; Sulfonamides; Sympathetic Nervous System | 2001 |